↓ Skip to main content

Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa

Overview of attention for article published in Stem Cell Research & Therapy, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
3 X users

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
Published in
Stem Cell Research & Therapy, April 2022
DOI 10.1186/s13287-022-02828-w
Pubmed ID
Authors

Christina Brown, Patrina Agosta, Christina McKee, Keegan Walker, Matteo Mazzella, Ali Alamri, David Svinarich, G. Rasul Chaudhry

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 10%
Student > Postgraduate 2 10%
Student > Ph. D. Student 1 5%
Unspecified 1 5%
Student > Bachelor 1 5%
Other 0 0%
Unknown 14 67%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 10%
Medicine and Dentistry 2 10%
Immunology and Microbiology 1 5%
Unspecified 1 5%
Neuroscience 1 5%
Other 1 5%
Unknown 13 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2023.
All research outputs
#13,339,920
of 23,510,717 outputs
Outputs from Stem Cell Research & Therapy
#913
of 2,480 outputs
Outputs of similar age
#175,975
of 444,049 outputs
Outputs of similar age from Stem Cell Research & Therapy
#22
of 81 outputs
Altmetric has tracked 23,510,717 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,480 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,049 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.